ATE361365T1 - Streptococcus pneumoniae proteine und nukleinsäuren - Google Patents

Streptococcus pneumoniae proteine und nukleinsäuren

Info

Publication number
ATE361365T1
ATE361365T1 AT99934989T AT99934989T ATE361365T1 AT E361365 T1 ATE361365 T1 AT E361365T1 AT 99934989 T AT99934989 T AT 99934989T AT 99934989 T AT99934989 T AT 99934989T AT E361365 T1 ATE361365 T1 AT E361365T1
Authority
AT
Austria
Prior art keywords
streptococcus pneumoniae
nucleic acids
pneumoniae proteins
proteins
vaccines
Prior art date
Application number
AT99934989T
Other languages
English (en)
Inventor
Christophe Francois Gu Gilbert
Philip Michael Hansbro
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816337.1A external-priority patent/GB9816337D0/en
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Application granted granted Critical
Publication of ATE361365T1 publication Critical patent/ATE361365T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99934989T 1998-07-27 1999-07-27 Streptococcus pneumoniae proteine und nukleinsäuren ATE361365T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9816337.1A GB9816337D0 (en) 1998-07-27 1998-07-27 Proteins
US12516499P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
ATE361365T1 true ATE361365T1 (de) 2007-05-15

Family

ID=26314125

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99934989T ATE361365T1 (de) 1998-07-27 1999-07-27 Streptococcus pneumoniae proteine und nukleinsäuren

Country Status (5)

Country Link
EP (2) EP1100921B1 (de)
JP (6) JP2002531055A (de)
AT (1) ATE361365T1 (de)
DE (1) DE69935986D1 (de)
WO (1) WO2000006737A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
CA2355364C (en) * 1998-12-21 2014-03-18 Medimmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
EP1950302B1 (de) 1998-12-23 2012-12-05 ID Biomedical Corporation of Quebec Streptokokken-Antigene
PL205041B1 (pl) * 1998-12-23 2010-03-31 Id Biomedical Corp Izolowany polinukleotyd, wektor zawierający izolowany polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca polipeptyd oraz jej zastosowanie w leczeniu lub zapobieganiu zakażeniu osobnika paciorkowcem
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
EP1075841A1 (de) * 1999-08-13 2001-02-14 Erasmus Universiteit Rotterdam Pneumokokkus Impfstoffe
WO2001098334A2 (en) * 2000-06-20 2001-12-27 Shire Biochem Inc. Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
AU2001281168A1 (en) 2000-08-08 2002-02-18 St. Jude Children's Research Hospital Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
US7892552B2 (en) 2001-08-08 2011-02-22 University Of Utah Research Foundation Group B Streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
US7939087B2 (en) 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
EP1343895B1 (de) 2000-12-21 2008-06-18 ID Biomedical Corporation Antigene aus streptococcus pyogenes und zugehörige dna-fragmente
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
US7262024B2 (en) 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
CN100443116C (zh) * 2002-11-07 2008-12-17 新纳几美国公司 治疗或预防肺炎球菌感染的组合物及其用途
US7635487B2 (en) * 2003-04-15 2009-12-22 Intercell Ag S. pneumoniae antigens
US7709009B2 (en) 2003-07-31 2010-05-04 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
AU2004289295B2 (en) * 2003-11-10 2010-08-12 The Uab Research Foundation Compositions for reducing bacterial carriage and CNS invasion and methods of using same
US20110002962A1 (en) 2006-08-17 2011-01-06 The Uab Research Foundation Immunogenic PcpA Polypeptides and Uses Thereof
US8722055B2 (en) 2006-09-27 2014-05-13 St. Jude Children's Research Hospital Synthetic Streptococcus pneumoniae vaccine
WO2008127094A2 (en) * 2007-04-12 2008-10-23 Stichting Katholieke Universiteit, More Particularly The Radboud University Nijmegen Medical Center New virulence factors of streptococcus pnuemoniae
CN101688194B (zh) 2007-05-23 2013-09-11 Uab研究基金会 去毒的肺炎球菌神经氨酸酶及其用途
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US8287885B2 (en) 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
SI2268618T1 (sl) 2008-03-03 2015-09-30 Novartis Ag Spojine in sestavki kot modulatorji aktivnosti TLR
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
US9950062B2 (en) 2009-09-02 2018-04-24 Glaxosmithkline Biologicals Sa Compounds and compositions as TLR activity modulators
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
JP5814933B2 (ja) 2009-12-15 2015-11-17 ノバルティス アーゲー 免疫増強化合物の均質な懸濁物およびその使用
ES2557431T3 (es) 2010-02-23 2016-01-26 Stichting Katholieke Universiteit Vacuna de combinación para Streptococcus
JP2013525271A (ja) 2010-03-12 2013-06-20 チルドレンズ メディカル センター コーポレーション 免疫原およびそのスクリーニング方法
EA031379B1 (ru) 2010-03-23 2018-12-28 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
WO2013131983A1 (en) 2012-03-07 2013-09-12 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
US9827190B2 (en) 2013-02-01 2017-11-28 Glaxosmithkline Biologicals Sa Intradermal delivery of immunological compositions comprising toll-like receptor 7 agonists
EP4272750A3 (de) 2013-02-07 2024-01-24 Children's Medical Center, Corp. Proteinantigene zum schutz gegen pneumokokkenkolonisation und/oder -befall
GB201509782D0 (en) * 2015-06-05 2015-07-22 Isis Innovation Methods and products for fusion protein synthesis
BR112020016314A2 (pt) 2018-02-12 2020-12-15 Inimmune Corporation Compostos ou um sais farmaceuticamente aceitáveis, composição farmacêutica, kit, e, métodos para elicitar, intensificar ou modificar uma resposta imunológica, para tratar, prevenir ou reduzir a suscetibilidade a câncer, para tratar, prevenir ou reduzir a suscetibilidade a uma doença infecciosa, para tratar, prevenir ou reduzir a suscetibilidade a uma alergia, para tratar, prevenir ou reduzir a suscetibilidade a uma afecção autoimune, para tratar, prevenir ou reduzir a suscetibilidade em um sujeito à infecção bacteriana, viral, priônica, autoimunidade, câncer ou alergia, para tratar, prevenir ou reduzir a suscetibilidade à autoimunidade, alergia, reperfusão de isquemia ou sepse, para tratar, prevenir ou reduzir a gravidade de ataques epiléticos e para tratar, prevenir ou reduzir a suscetibilidade a doenças oculares como degeneração macular, hipertensão ocular e infecção ocular
CN112969474A (zh) 2018-09-12 2021-06-15 艾芬尼维克斯公司 多价肺炎球菌疫苗
KR20230117105A (ko) 2020-11-04 2023-08-07 엘리고 바이오사이언스 큐티박테리움 아크네스 재조합 파지, 그의 제조 방법 및 용도
MX2024002779A (es) 2021-09-09 2024-06-11 Affinivax Inc Vacunas neumocócicas multivalentes.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
EP0956289A4 (de) * 1996-08-16 2004-10-13 Smithkline Beecham Corp Prokaryotische polynucleotide, polypeptide und ihre verwendung
ATE348887T1 (de) * 1996-10-31 2007-01-15 Human Genome Sciences Inc Streptococcus pneumoniae antigene und impfstoffe
EP0885966A3 (de) * 1997-06-20 1999-12-29 Smithkline Beecham Corporation Neue Verbindungen
EP0891984A3 (de) * 1997-06-20 2000-01-19 Smithkline Beecham Corporation Nukleinsäure kodierend für streptococcus pneumoniae response-regulator
EP1783224A3 (de) * 1998-07-27 2007-08-15 Sanofi Pasteur Limited Streptococcus pneumoniae Proteine und Nukleinsäuren

Also Published As

Publication number Publication date
WO2000006737A2 (en) 2000-02-10
JP2008263966A (ja) 2008-11-06
WO2000006737A8 (en) 2000-11-09
JP2009148283A (ja) 2009-07-09
JP2002531055A (ja) 2002-09-24
EP1100921B1 (de) 2007-05-02
JP2008263970A (ja) 2008-11-06
EP2053126A1 (de) 2009-04-29
DE69935986D1 (de) 2007-06-14
EP1100921A2 (de) 2001-05-23
JP2008263968A (ja) 2008-11-06
WO2000006737A3 (en) 2000-06-29
JP2008263969A (ja) 2008-11-06

Similar Documents

Publication Publication Date Title
DE69935986D1 (de) Streptococcus pneumoniae proteine und nukleinsäuren
WO2000006738A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
WO2000039299A3 (en) Streptococcus antigens
WO2000006736A3 (en) Nucleic acids and proteins from group b streptococcus
ATE479756T1 (de) Streptococcus pneumoniae-antigene und impfstoffe
DK1093517T3 (da) Neisseria-meningitidis-antigener og præparater
DE69731285D1 (de) Langwellig fluorezierende proteine
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
WO1999042588A3 (en) Group b streptococcus antigens
EA200201280A1 (ru) Стрептококковые антигены
WO2001032882A3 (en) Nucleic acids and proteins from group b streptococcus
WO2002079241A3 (en) Secreted streptococcus pneumoniae proteins
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
ATE350055T1 (de) Hämophilus influenzae adhärenz und penatrationsproteine
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
ATE439441T1 (de) Veränderte, fluoreszierende proteine
ATE134219T1 (de) Menschliches mk gen und protein-sequenz
WO2003016551A3 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
DE69728897D1 (de) Saeugetierchemokine
ATE435277T1 (de) 18477, eine menschliche proteinkinase und deren verwendung
EP1790730A3 (de) Pneumokokkenproteine und Nukleinsäuremoleküle
DE69935323D1 (de) Moraxella catharralis proteine
DE60037413D1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
DK1241179T3 (da) Humant protein med in vitro antiproliferativ aktivitet.
EP1624064A3 (de) Nukleinsäuren und entsprechende Proteine aus streptococcus pneumoniae

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties